Ophthalmic Squeeze Dispenser and ESG

With around 70% of the world economy now covered by net zero targets, and recent research suggesting that 80% of consumers want to see less plastic packaging, post-pandemic, there is an urgent need for more sustainable pharmaceutical solutions.

This case study compares the packaging weight and associated Global Warming Potential (GWP) of Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD), a multi-dose preservative-free eye dropper, with the widely used delivery format of Blow-Fill-Seal (BFS) single use vials. By reducing the amount of primary packaging material used and minimizing medication waste the OSD multi-dose preservative-free eyedropper delivers a more sustainable pharmaceutical solution for eyecare, with a lower GWP.

Aptar Pharma is committed to developing sustainable pharmaceutical solutions by, for example, maximizing the use of renewable energies, effective recycling, and innovative product design. The OSD multi-dose preservative-free eye dropper exemplifies the progress already made.

Download the full paper by signing in

Aptar Pharma
Aptar Pharma

Aptar Pharma is a trusted partner to many pharmaceutical companies to bring drug delivery solutions to market quickly and efficiently.

As a global leader in drug delivery, consumer product dispensing and active material science solutions, we use insights, design, engineering and science to create dosing, dispensing and protective packaging technologies for the world’s leading brands – small marvels of sophisticated engineering and innovative design that make a meaningful difference in the lives, looks, health and homes of millions of people around the world.

Share on facebook
Share on twitter
Share on linkedin

How Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD) is Contributing to Overall ESG Commitments

Get It Now, For Free

By clicking submit/download above, you consent to allow Packaging 360 to store and process the personal information submitted above to provide you the content requested, and deliver subsequent contents. You may unsubscribe from these communications at any time.

Reach Us